These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25944898)

  • 21. Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake.
    Gao XF; Chen W; Kong XP; Xu AM; Wang ZG; Sweeney G; Wu D
    Diabetologia; 2009 May; 52(5):912-20. PubMed ID: 19224198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TCF7L2 modulates glucose homeostasis by regulating CREB- and FoxO1-dependent transcriptional pathway in the liver.
    Oh KJ; Park J; Kim SS; Oh H; Choi CS; Koo SH
    PLoS Genet; 2012 Sep; 8(9):e1002986. PubMed ID: 23028378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
    Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Forkhead Box P1 (FOXP1) Transcription Factor Regulates Hepatic Glucose Homeostasis.
    Zou Y; Gong N; Cui Y; Wang X; Cui A; Chen Q; Jiao T; Dong X; Yang H; Zhang S; Fang F; Chang Y
    J Biol Chem; 2015 Dec; 290(51):30607-15. PubMed ID: 26504089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated TGF-β1 contributes to hyperglycaemia in type 2 diabetes by potentiating glucagon signalling.
    Xiao Y; Wang Y; Ryu J; Liu W; Zou H; Zhang R; Yan Y; Dai Z; Zhang D; Sun LZ; Liu F; Zhou Z; Dong LQ
    Diabetologia; 2023 Jun; 66(6):1142-1155. PubMed ID: 36917279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.
    Cotter DG; Ercal B; Huang X; Leid JM; d'Avignon DA; Graham MJ; Dietzen DJ; Brunt EM; Patti GJ; Crawford PA
    J Clin Invest; 2014 Dec; 124(12):5175-90. PubMed ID: 25347470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure.
    Liu W; Singh R; Choi CS; Lee HY; Keramati AR; Samuel VT; Lifton RP; Shulman GI; Mani A
    J Biol Chem; 2012 Mar; 287(10):7213-23. PubMed ID: 22232553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor functions in pericentral hepatocytes to decrease gluconeogenesis and avoid hyperglycemia and obesity in male mice.
    Chen KW; Chen YS; Chen PJ; Yeh SH
    Metabolism; 2022 Oct; 135():155269. PubMed ID: 35914621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of pregnane X receptor in obesity and glucose homeostasis in male mice.
    Spruiell K; Richardson RM; Cullen JM; Awumey EM; Gonzalez FJ; Gyamfi MA
    J Biol Chem; 2014 Feb; 289(6):3244-61. PubMed ID: 24362030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of FOXO transcription factors in the liver mitigates stress-induced hyperglycemia.
    Garcia Whitlock AE; Sostre-Colón J; Gavin M; Martin ND; Baur JA; Sims CA; Titchenell PM
    Mol Metab; 2021 Sep; 51():101246. PubMed ID: 33964506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility to diet-induced hepatic steatosis and glucocorticoid resistance in FK506-binding protein 52-deficient mice.
    Warrier M; Hinds TD; Ledford KJ; Cash HA; Patel PR; Bowman TA; Stechschulte LA; Yong W; Shou W; Najjar SM; Sanchez ER
    Endocrinology; 2010 Jul; 151(7):3225-36. PubMed ID: 20427484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
    Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
    Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR2 knockout exacerbates cerulein-induced chronic pancreatitis with hyperglycemia via decreased GLP-1 receptor expression and insulin secretion.
    Nakamura Y; Kanai T; Saeki K; Takabe M; Irie J; Miyoshi J; Mikami Y; Teratani T; Suzuki T; Miyata N; Hisamatsu T; Nakamoto N; Yamagishi Y; Higuchi H; Ebinuma H; Hozawa S; Saito H; Itoh H; Hibi T
    Am J Physiol Gastrointest Liver Physiol; 2013 Apr; 304(8):G700-7. PubMed ID: 23449669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis.
    Gray LR; Sultana MR; Rauckhorst AJ; Oonthonpan L; Tompkins SC; Sharma A; Fu X; Miao R; Pewa AD; Brown KS; Lane EE; Dohlman A; Zepeda-Orozco D; Xie J; Rutter J; Norris AW; Cox JE; Burgess SC; Potthoff MJ; Taylor EB
    Cell Metab; 2015 Oct; 22(4):669-81. PubMed ID: 26344103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice.
    Kim DH; Lee B; Lee J; Kim ME; Lee JS; Chung JH; Yu BP; Dong HH; Chung HY
    Redox Biol; 2019 Jun; 24():101184. PubMed ID: 30974318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kaempferol ameliorates hyperglycemia through suppressing hepatic gluconeogenesis and enhancing hepatic insulin sensitivity in diet-induced obese mice.
    Alkhalidy H; Moore W; Wang A; Luo J; McMillan RP; Wang Y; Zhen W; Hulver MW; Liu D
    J Nutr Biochem; 2018 Aug; 58():90-101. PubMed ID: 29886193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
    Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
    Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.